Medicare spending analysis for Medical Oncology providers
Medical Oncology accounts for $8.6B in Medicare payments across 32.6K providers.
The specialty's average markup of 3.6x is below the overall Medicare average of 3.77x.
AI-generated analysis based on Medicare payment data.
Providers in this specialty flagged by the ML v2 fraud detection model
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2014 | $733.3M | 64.4M | 2.8K | — |
| 2015 | $735.3M | 66.2M | 3.0K | +0.3% |
| 2016 | $818.8M | 70.9M | 3.0K | +11.4% |
| 2017 | $846.9M | 69.3M | 3.1K | +3.4% |
| 2018 | $915.9M | 73.5M | 3.2K | +8.1% |
| 2019 | $994.3M | 79.9M | 3.3K | +8.6% |
| 2020 | $897.3M | 71.5M | 3.4K | -9.8% |
| 2021 | $896.6M | 67.5M | 3.5K | -0.1% |
| 2022 | $869.6M | 65.3M | 3.6K | -3.0% |
| 2023 | $854.3M | 61.5M | 3.6K | -1.8% |
| # | Provider | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| 1 | Thomas Buroker | IA | $9.4M | 577.3K | $16.22 |
| 2 | William Sharfman | MD | $9.1M | 223.8K | $40.83 |
| 3 | James Uyeki | TX | $6.7M | 408.8K | $16.32 |
| 4 | Robert Behrens | IA | $5.2M | 322.0K | $16.08 |
| 5 | Brian Dicarlo | CA | $4.7M | 250.2K | $18.95 |
| 6 | Mitchell Martin | TN | $4.7M | 292.5K | $16.03 |
| 7 | Petros Nikolinakos | GA | $4.6M | 121.8K | $37.86 |
| 8 | Jay Wang | FL | $4.5M | 427.2K | $10.62 |
| 9 | Alexander Zuhoski | NY | $4.4M | 386.4K | $11.49 |
| 10 | Philip Dy | IL | $4.4M | 471.4K | $9.35 |
| 11 | Yi Feng | TN | $4.0M | 285.3K | $13.86 |
| 12 | Stephen Divers | AR | $3.9M | 331.7K | $11.74 |
| 13 | Kurt Tauer | TN | $3.9M | 196.4K | $19.80 |
| 14 | Ronald Drengler | TX | $3.8M | 223.5K | $17.07 |
| 15 | Jason Chandler | TN | $3.8M | 204.5K | $18.40 |
| 16 | Thomas Niederman | FL | $3.8M | 299.4K | $12.53 |
| 17 | Charles Butler | SC | $3.8M | 267.0K | $14.05 |
| 18 | Luke Nordquist | NE | $3.7M | 72.5K | $50.77 |
| 19 | Sujal Shah | FL | $3.6M | 177.8K | $20.25 |
| 20 | Amy Mcmullen | CA | $3.5M | 148.0K | $23.95 |
| 21 | Aaron Flanders | SC | $3.5M | 385.7K | $9.16 |
| 22 | Ahmed Al-Hazzouri | FL | $3.5M | 293.8K | $12.01 |
| 23 | Scott Lunin | FL | $3.5M | 263.5K | $13.24 |
| 24 | Daniel Greenwald | CA | $3.5M | 115.0K | $30.13 |
| 25 | Bruce Saidman | PA | $3.4M | 437.1K | $7.87 |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | $265.8M | 6.2M | $42.66 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $81.9M | 954.7K | $85.74 |
| J0897 | Injection, denosumab, 1 mg | $59.3M | 3.3M | $18.21 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | $52.5M | 434.1K | $120.91 |
| J9299 | Injection, nivolumab, 1 mg | $52.0M | 2.2M | $23.42 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | $52.0M | 1.4M | $37.84 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | $23.9M | 236.3K | $101.24 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $21.0M | 353.6K | $59.33 |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | $12.8M | 83.8K | $152.41 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | $12.1M | 340.5K | $35.66 |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | $11.8M | 10.4K | $1.1K |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $10.1M | 102.7K | $98.10 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | $8.9M | 271.3K | $32.88 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | $8.6M | 3.7M | $2.34 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $6.6M | 104.6K | $63.29 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | $6.1M | 7.0M | $0.87 |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | $5.1M | 674.3K | $7.57 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | $5.0M | 103.4K | $48.63 |
| 36415 | Insertion of needle into vein for collection of blood sample | $4.8M | 583.4K | $8.30 |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | $4.8M | 59.4K | $80.26 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.